4 月 11, 2023
HanchorBio Completes the Face-to-Face Scientific Advisory Board Meeting
11 月 12, 2022
HanchorBio Founder and Chief Executive Officer Dr. Scott Liu Receives Award from Chinese-American Biopharmaceutical Society 漢康生技創始人兼執行長 劉世高博士榮獲 北美華人生物醫藥協會2022年度方瑞賢生命科學獎
Dr. Liu was awarded on November 12, 2022, as part of the CABS 23rd Annual BioPacific Conference entitled, “Resilience and Ingenuity – Embracing Opportunities in a New Normal”. The theme this year reflects economic and supply chain turbulences that have presented both new challenges and opportunities for the life sciences and biopharmaceutical industries, despite ongoing COVID-19. For the past 24 years, CABS has been one of the largest and most active non-profit biopharmaceutical organizations in western United States.
4 月 13, 2023
HanchorBio Completes the Face-to-Face Scientific Advisory Board Meeting 漢康生技成功舉辦SAB科學顧問委員會會議
HanchorBio Inc. completed a face-to-face Scientific Advisory Board (SAB) meeting on March 29, 2023, in Taipei, Taiwan withworld-renowned professors and few Board of Director (BOD) members.漢康生技（HanchorBio Inc.）於2023年3月29日在台北內湖總部成功舉辦了(SAB)科學顧問委員會會議。